NSETrading Window28 Sept 2026 · 28 Sept 2026, 05:14 pm

Trading Window

Nath Bio-Genes (India) Limited · NATHBIOGEN

✦ AI Summary

Nath Bio-Genes (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Analysis Scores

Earnings Impact5/10

Growth Catalyst5/10

Governance Concern1/10

Regulatory Risk1/10

Balance Sheet Risk1/10

Liquidity Impact5/10

Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

Full Announcement

Nath Bio-Genes (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

NATHBIOGEN_28092026171425_NBIL_TWC_300926_SIGNED.pdf

pdf

Download →

View document text

28th September 2026 The Manager-Listing The Manager-Listing BSE Limited National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex Dalal Street, Bandra (E) Mumbai-400001 Mumbai-400051 BSE Code-537291 NSE Code-NATHBIOGEN Sub: Intimation of Closure of Trading Window. Dear Sir, This is to inform that in terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct for Prevention of Insider Trading ("PIT Code"), the trading window for dealing in securities of the Company shall remain closed from Thursday, 01st October, 2026 up to 48 hours after the declaration of unaudited financial results of the Company for the quarter and half year ending 30th September, 2026. The date of the Board Meeting of the Company for declaration of unaudited financial results for the quarter and half year ending 30th September, 2026 will be intimated separately. This is for your information and record purpose. Thanking You. Yours faithfully, For Nath Bio-Genes (India) Limited Amol Gupta Chief Financial Officer